It was indeed a comprehensive report that gave us revenue impacting solution enabling us to plan the right move. We were impressed by the in-depth customization and inclusion of not only major but also minor players across the globe. The DBMR Market position grid helped us to analyze the market in different dimension which was very helpful for the team to get into the minute details.
How Is The Pharmaceutical Drugs Market Segmented?
Other prominent players, such as Viatris, AstraZeneca, AbbVie, Inc., and Lupin Pharmaceuticals, Inc., are focusing on producing and launching generic equivalents of many specialty and orphan drugs. Drug manufacturers’ initiatives are projected to gain substantial market share during the forecast period and positively impact the U.S. market. Fulfilling an essential need within healthcare, the Institute delivers objective, relevant insights and research that accelerate understanding and innovation critical to sound decision making and improved human outcomes. Maintaining impeccable quality is not just a regulatory requirement but a matter of public trust. The report highlights significant growthpotential across emerging markets, advancements in biopharmaceuticals, andincreasing investments in personalized medicine and innovative drug deliverysystems.
Emphasizing Personalized Medicine For Targeted Therapies In Pharma
An undisputable contributing factor to this overdose crisis is prescription opioids, which were widely available at the turn of the century and coupled with insufficient regulation of the pharmaceutical and healthcare industries 44. Strong prescription control was then put in place, but without an expansion of pain and addiction treatment 44. Among the many unintended consequences of such restrictions on prescribing practices included the growth of illicit drug market with counterfeit pills, heroin, and eventually fentanyl 44. Although prescription opioid-involved deaths rates have remained relatively stable, it is important to remember what role prescription drug-control policies had in shaping the nature of today’s drug markets 5. The substance is widely used in the growing geriatric population, chronic and lifestyle diseases, and breakthroughs in drug development and technology encompass biologics, AI, and precision medicine is termed a drug.
Samruddhi Yardi has done her MBA in Marketing, and after working in sales for 4+ years, she has shifted to the market research industry. In 2024, Merck’s Keytruda continued its reign with nearly $29.5 billion in sales, posting solid 17.9% growth over 2023. Thankful to the team for the amazing coordination, and helping me at the last moment with my presentation.
The Future Trajectory Of North American Drug Markets
The growing use of AI isexpected to accelerate innovation in areas like oncology, neurology, andinfectious diseases. Key factors that are driving the market growth include increasing chronic disease prevalence, rising geriatric population, increasing healthcare spending by government organizations globally, and extensive efforts to improve the affordability of pharmaceuticals. The adults segment held the largest market share of 62.84% in 2024 and is anticipated to grow at the fastest CAGR over the forecast period. The adult population aged from years holds the largest share in the total population and are the major consumer of prescription medicine. According to CDC,in U.S., around 69.0% and in Canada, around 65.5%, accounting to nearly 7 in 10 persons aged used at least one prescription drug. The most commonly used drug among the adult population includes lipid-lowering drugs, ACE inhibitors, analgesics, and antidepressants.
A Brief History: From Policy Catalyst To Global Juggernaut
For instance, Abiraterone used in the treatment of prostate cancer can cost the patient USD 10,000 per month at its lowest and not even cure the disease. Thus, such restraining factors are anticipated to limit the market growth during the forecast period. India, often called the “pharmacy of the world,” maintains a crucial position due to its large generic drug manufacturing industry and growing biosimilars sector. Companies such as Sun Pharma, Dr. Reddy’s Laboratories, and Cipla are major players contributing to affordable medication availability globally. Government initiatives supporting pharmaceutical exports and continuous improvements in intellectual property enforcement have strengthened India’s role as a supplier of cost-effective medicines.
What Are The Government Initiatives For The Drugs Market?
For the better understanding the recent situation of the global generic drugs market and for most policies of the country, Precedence Research forecast the future evolution of the generic drugs industry. This research study offers qualitative and measureable insights on generic drugs market and valuation of market size and development trends for global market segments. The high cost of branded oncology drugs can pose significant financial burdens on healthcare systems, insurers, and patients.
Latest Developments In Global Prescription Drugs Market
Latin America pharmaceutical market is witnessing growth in the pharmaceutical market, supported by increasing healthcare expenditure and rising awareness of advanced treatment options. Brazil is the key market, driven by government health initiatives and investments in local biopharmaceutical manufacturing. The rising prevalence of chronic and infectious diseases is fostering demand for effective therapies. The pharmaceutical market in the U.S. is the largest in North America, supported by strong government policies, high consumer spending, and extensive biopharma investments. Increasing FDA approvals and the expanding pipeline of specialty treatments further accelerate market growth. Hospital pharmacies remain the dominant distribution channel, with retail pharmacies enhancing access to chronic disease treatments.
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. Empowering patients to personalize their healthcare and connecting them to caregivers has the potential to change the care delivery paradigm. The IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale. An in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise. Explore our library of insights, thought leadership, and the latest topics & trends in healthcare.
- Governments in Europe striving to make healthcare affordable in Europe is also helping the market’s development.
- Even the emergence and decline of specific drugs has little effect; deadly as fentanyl is, statistically, it looks merely like an extension of what was even in 2015 a 35-year trend.
- This segment is driven by several key factors, including increasing patent expirations, rising healthcare cost pressures, and supportive regulatory frameworks that streamline generic drug approvals.
- Moreover, the increased production of low-cost generic drugs by significant drug manufacturers is expanding their presence in the U.S. market, catering to market growth.
- The TrumpRx website is expected to be operating by early 2026, according to a senior Trump administration official.
The other prescription drugs segment is expected to be the leading segment in this market during the forecast period. Fortune Business Insights says that the global prescription drugs market size was USD 1,162.61 billion in 2023 and is projected to reach USD 2,151.63 billion by 2032. Moreover, the others segment held a dominant share of the market in 2023, owing to the increasing launch and sales of drugs by key players and the rising number of prescriptions of these drugs by healthcare professionals across the globe. The increasing prevalence of cardiovascular diseases is also anticipated to drive the anticoagulants segment. Increasing organ transplant procedures is also anticipated to drive the growth of the immunosuppressants segments. Moreover, rising demand and sales of immunomodulatory drugs to treat high prevalence of immunological disorders further boost the segment share.
World Drug Report 2024
Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report. The homecare segment is expected to grow at the fastest CAGR of 8.5% from 2025 to 2032, driven by patient preference for convenience, aging demographics, and growing home-based care models. Drug enforcement is about market regulation, yet the federal government makes little effort to collect systematic market data. Restoring researcher access to the System to Retrieve Information from Drug Evidence (STRIDE), the Drug Enforcement Agency’s data system for drug price and purity, is an easy first step. Other relatively easy steps are to strengthen the National Forensic Lab Information System (NFLIS), a national seizure database, and reestablish drug abuse monitoring programs among justice-involved populations, as well as the adoption of wastewater drug monitoring.
The parenteral route of administration is experiencing the fastest growth rate in the market due to its rapid drug absorption, immediate therapeutic effect, and suitability for patients unable to take oral medications. It is widely used for biologics, vaccines, and cancer treatments, driving demand amid the rising prevalence of chronic and infectious diseases. Technological advancements in injectable devices, increasing hospital admissions, and the growing use of prefilled syringes further support this growth. In addition, the need for targeted drug delivery and patient-specific therapies contributes to the parenteral segment’s market expansion.
